7 Incredible Reasons to Buy Pfizer Stock Right Now
https://www.fool.com/investing/2024/01/13/7-reasons-to-buy-pfizer-stock/?source=iedfolrf0000001
Jan 13, 2024 - The company's work should pay off eventually.
0
Pfizer (PFE) Flat As Market Sinks: What You Should Know
https://www.zacks.com/stock/news/2205278/pfizer-pfe-flat-as-market-sinks-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2205278
Jan 03, 2024 - Pfizer (PFE) closed the most recent trading day at $29.73, making no change from the previous trading session.
0
Got $5,000? Buy and Hold These 3 Value Stocks for Years
https://www.fool.com/investing/2023/12/30/got-5000-buy-and-hold-these-3-value-stocks-for-yea/?source=iedfolrf0000001
Dec 30, 2023 - Sometimes it pays for investors to take a step back and look at the (much) bigger, longer-term picture.
0
Are Investors Overreacting to Pfizer's Underwhelming Forecast for 2024?
https://www.fool.com/investing/2023/12/23/are-investors-overreacting-to-pfizer-underwhelming/?source=iedfolrf0000001
Dec 23, 2023 - Is Pfizer stock a bargain buy?
0
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
https://www.fool.com/investing/2023/12/23/invivyd-stock-more-than-doubled-last-week-is/?source=iedfolrf0000001
Dec 23, 2023 - The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.
0
Pharma Stock Roundup: FDA Nod to AZN's Eplontersen, CRL to MRK's Cough Candidate
https://www.zacks.com/stock/news/2201507/pharma-stock-roundup-fda-nod-to-azn-s-eplontersen-crl-to-mrk-s-cough-candidate?cid=CS-ZC-FT-analyst_blog|stock_roundup-2201507
Dec 22, 2023 - FDA approves AstraZeneca (AZN) and Ionis' (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Merck's chronic cough candidate, gefapixant.
0
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
https://www.fool.com/investing/2023/12/21/weighing-their-chances-5-leading-healthcare-compan/?source=iedfolrf0000001
Dec 21, 2023 - Which weight-loss stocks are good buys today?
0
FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab
https://www.zacks.com/stock/news/2200645/fda-accepts-merck-s-mrk-bla-for-21-valent-pneumococcal-jab?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200645
Dec 20, 2023 - The FDA grants priority review to Merck's (MRK) filing seeking approval for its 21-valent pneumococcal conjugate vaccine in adults. A final decision is expected in June 2024.
0
Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev
https://www.zacks.com/stock/news/2200049/pfizer-pfe-stock-rises-on-fda-nod-for-expanded-use-of-padcev?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200049
Dec 19, 2023 - The FDA approves Pfizer's (PFE) Padcev in combination with Merck's (MRK) Keytruda for adult patients with advanced bladder cancer. Stock rises 1.6%.
0
Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?
https://www.fool.com/investing/2023/12/18/pfizer-slashed-its-guidance-but-is-it-still-a-buy/?source=iedfolrf0000001
Dec 18, 2023 - It's no secret that the next couple of years will be slow.
0